Effects of oral adenosine-5′-triphosphate supplementation on athletic performance, skeletal muscle hypertrophy and recovery in resistance-trained men

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Wilson, Jacob M ^a   Joy, Jordan M ^a   Lowery, Ryan P ^a   Roberts, Michael D ^b   Lockwood, Christopher M ^c   Manninen, Anssi H ^d   Fuller, John C ^e   De Souza, Eduardo O ^f   Baier, Shawn M ^e   Wilson, Stephanie M c ^g   Rathmacher, John A ^e  

^a UNIVERSITY OF TAMPA   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c AP Nutrition   (United States)

^d Metabolia Oulu   (Finland)

^e IOWA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g IMG Academies   (United States)

Author keywords

Adenosine triphosphate; Exercise performance; Muscle hypertrophy; Power; Sports nutrition; Strength

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROCORTISONE; MUSCLE PROTEIN; PLACEBO;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; MUSCLE HYPERTROPHY; MUSCLE MASS; MUSCLE STRENGTH; MUSCLE THICKNESS; PHASE 3 CLINICAL TRIAL; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; TREATMENT DURATION; ULTRASOUND; VITAMIN SUPPLEMENTATION;

EID: 84884345241     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-57     Document Type: Article

References (34)

1. Energetics of muscle contraction: the whole is less than the sum of its parts. Kushmerick MJ, Conley KE, Biochem Soc Trans 2002 30 2 227 231 12023856
2. Purinergic signaling in healthy and diseased skin. Burnstock G, Knight GE, Greig AV, J Invest Dermatol 2012 132 3 Pt 1 526 546 22158558
3. Adenosine triphosphate: established and potential clinical applications. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH, Drugs 1999 58 2 211 232 10.2165/00003495-199958020-00002 10473017
4. The role of purines in nociception. Sawynok J, Sweeney MI, Neuroscience 1989 32 3 557 569 10.1016/0306-4522(89)90278-9 2689906 (Pubitemid 20008285)
5. ATP receptor-mediated enhancement of fast excitatory neurotransmitter release in the brain. Khakh BS, Henderson G, Mol Pharmacol 1998 54 2 372 378 9687579 (Pubitemid 28368827)
6. Human plasma ATP concentration. Gorman MW, Feigl EO, Buffington CW, Clin Chem 2007 53 2 318 325 17185366 (Pubitemid 46338277)
7. On the role of actomyosin ATPases in regulation of ATP turnover rates during intense exercise. Hochachka PW, Bianconcini MS, Parkhouse WS, Dobson GP, Proc Natl Acad Sci U S A 1991 88 13 5764 5768 10.1073/pnas.88.13.5764 1829528 (Pubitemid 21914826)
8. Local release of ATP into the arterial inflow and venous drainage of human skeletal muscle: insight from ATP determination with the intravascular microdialysis technique. Mortensen SP, Thaning P, Nyberg M, Saltin B, Hellsten Y, J Physiol 2011 589 Pt 7 1847 1857 21300753
9. What is the efficiency of ATP signaling from erythrocytes to regulate distribution of O(2) supply within the microvasculature? Ellis CG, Milkovich S, Goldman D, Microcirculation 2012 19 5 440 450 10.1111/j.1549-8719.2012.00196.x 22587367
10. Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle. Sprague RS, Bowles EA, Achilleus D, Ellsworth ML, Acta Physiol 2011 202 3 285 292 10.1111/j.1748-1716.2010.02182.x
11. Extracellular ATP, in the immune system: more than just a "danger signal" Trautmann A, Sci Signal 2009 2 56 e6 10.1126/scisignal.256pe6 19193605
12. Chronic oral administration of ATP modulates nucleoside transport and purine metabolism in rats. Kichenin K, Seman M, J Pharmacol Exp Ther 2000 294 1 126 133 10871303 (Pubitemid 30434678)
13. Effects of oral ATP supplementation on anaerobic power and muscular strength. Jordan AN, Jurca R, Abraham EH, Salikhova A, Mann JK, Morss GM, Church TS, Lucia A, Earnest CP, Med Sci Sports Exerc 2004 36 6 983 990 10.1249/01.MSS.0000128198.97260.8B 15179168 (Pubitemid 38720780)
14. Adenosine-5′-triphosphate (ATP) supplementation improves low peak muscle torque and torque fatigue during repeated high intensity exercise sets. Rathmacher JA, Fuller JC Jr, Baier SM, Abumrad NN, Angus HF, Sharp RL, Journal of the International Society of Sports Nutrition 2012 9 1 48 10.1186/1550-2783-9-48 23046855
15. Effects of amino acids supplement on physiological adaptations to resistance training. Kraemer WJ, Hatfield DL, Volek JS, Fragala MS, Vingren JL, Anderson JM, Spiering BA, Thomas GA, Ho JY, Quann EE, Izquierdo M, Hakkinen K, Maresh CM, Med Sci Sports Exerc 2009 41 5 1111 1121 10.1249/MSS.0b013e318194cc75 19346975
16. Changes in the force development characteristics of muscle following repeated maximum force and power exercise. Gilbert G, Lees A, Ergonomics 2005 48 11-14 1576 1584 16338723 (Pubitemid 43347827)
17. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. Weir JP, J Strength Cond Res 2005 19 1 231 240 15705040 (Pubitemid 40417282)
18. The effects of high-intensity exercise on a 10-second sprint cycle test. Smith JC, Fry AC, Weiss LW, Li Y, Kinzey SJ, J Strength Cond Res 2001 15 3 344 348 11710663 (Pubitemid 33657858)
19. The effects of potentiating stimuli intensity under varying rest periods on vertical jump performance and power. Lowery RP, Duncan NM, Loenneke JP, Sikorski EM, Naimo MA, Brown LE, Wilson FG, Wilson JM, J Strength Cond Res 2012 26 12 3320 3325 10.1519/JSC.0b013e318270fc56 23007485
20. Absence of the predisposing factors and signs and symptoms usually associated with overreaching and overtraining in physical fitness centers. Ackel-D'Elia C, Vancini RL, Castelo A, Nouailhetas VL, Silva AC, Clinics (Sao Paulo) 2010 65 11 1161 1166 10.1590/S1807-59322010001100019
21. Effect of loading on enhancement of power performance over three consecutive trials. Robbins DW, Docherty D, J Strength Cond Res 2005 19 4 898 902 16287358 (Pubitemid 41784050)
22. Meta-Analysis of Post Activation Potentiation and Power: Effects of Conditioning Activity, Volume, Gender, Rest Periods, and Training Status. Wilson JM, Duncan NM, Marin PJ, Brown LE, Loenneke JP, Wilson SM, Jo E, Lowery RP, Ugrinowitsch C, J Strength Cond Res 2013 27 3 854 859 10.1519/JSC. 0b013e31825c2bdb 22580978
23. Developing maximal neuromuscular power: Part 1-biological basis of maximal power production. Cormie P, McGuigan MR, Newton RU, Sports Med 2011 41 1 17 38 10.2165/11537690-000000000-00000 21142282
24. Developing maximal neuromuscular power: part 2-training considerations for improving maximal power production. Cormie P, McGuigan MR, Newton RU, Sports Med 2011 41 2 125 146 10.2165/11538500-000000000-00000 21244105
25. The T-tubule membrane ATP-operated P2X4 receptor influences contractility of skeletal muscle. Sandona D, Danieli-Betto D, Germinario E, Biral D, Martinello T, Lioy A, Tarricone E, Gastaldello S, Betto R, FASEB J 2005 19 9 1184 1186 15857823 (Pubitemid 40946459)
26. Calcium regulation of thin filament movement in an in vitro motility assay. Homsher E, Kim B, Bobkova A, Tobacman LS, Biophys J 1996 70 4 1881 1892 10.1016/S0006-3495(96)79753-9 8785348 (Pubitemid 26103961)
27. Muscle deoxygenation during repeated sprint running: Effect of active vs. passive recovery. Buchheit M, Cormie P, Abbiss CR, Ahmaidi S, Nosaka KK, Laursen PB, Int J Sports Med 2009 30 6 418 425 10.1055/s-0028-1105933 19437381
28. Interstitial and plasma adenosine stimulate nitric oxide and prostacyclin formation in human skeletal muscle. Nyberg M, Mortensen SP, Thaning P, Saltin B, Hellsten Y, Hypertension 2010 56 6 1102 1108 10.1161/HYPERTENSIONAHA.110. 161521 21041702
29. Haemodynamic responses to exercise, ATP infusion and thigh compression in humans: insight into the role of muscle mechanisms on cardiovascular function. Gonzalez-Alonso J, Mortensen SP, Jeppesen TD, Ali L, Barker H, Damsgaard R, Secher NH, Dawson EA, Dufour SP, J Physiol 2008 586 9 2405 2417 10.1113/jphysiol.2008.152058 18339690 (Pubitemid 351619188)
30. Effects of overtraining on skeletal muscle growth and gene expression. Xiao W, Chen P, Dong J, Int J Sports Med 2012 33 10 846 853 22592543
31. Serum sex hormone-binding globulin and cortisol concentrations are associated with overreaching during strenuous military training. Tanskanen MM, Kyrolainen H, Uusitalo AL, Huovinen J, Nissila J, Kinnunen H, Atalay M, Hakkinen K, J Strength Cond Res 2011 25 3 787 797 10.1519/JSC.0b013e3181c1fa5d 20543745
32. Does overtraining exist? An analysis of overreaching and overtraining research. Halson SL, Jeukendrup AE, Sports Med 2004 34 14 967 981 10.2165/00007256-200434140-00003 15571428 (Pubitemid 39665190)
33. Overtraining parameters in special military units. Chicharro JL, Lopez-Mojares LM, Lucia A, Perez M, Alvarez J, Labanda P, Calvo F, Vaquero AF, Aviat Space Environ Med 1998 69 6 562 568 9641402 (Pubitemid 28262266)
34. Oral bioavailability of ATP after prolonged administration. Coolen EJ, Arts IC, Bekers O, Vervaet C, Bast A, Dagnelie PC, Br J Nutr 2011 105 3 357 366 10.1017/S0007114510003570 21129239